Correlation of Hsp70 serum levels with gross tumor volume and composition of lymphocyte subpopulations in patients with squamous cell and adeno non-small cell lung cancer

Frontiers in Immunology

Volumn 6, Issue NOV, 2015, Pages

  Gunther, Sophie ^a   Ostheimer, Christian ^b   Stangl, Stefan ^a   Specht, Hanno M ^a   Mozes, Petra ^a   Jesinghaus, Moritz ^a   Vordermark, Dirk ^b   Combs, Stephanie E ^a,c   Peltz, Friedhelm ^a   Jung, Max P ^a   Multhoff, Gabriele ^a,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Biological; Biomarker; Gross tumor volume; Heat shock protein 70; Immune responses; Lymphocytes; NSCLC; Tumor markers

Indexed keywords

CD19 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; CD94 ANTIGEN; CISPLATIN; HEAT SHOCK PROTEIN 70; NATURAL KILLER CELL RECEPTOR NKG2D; NAVELBINE;

ADULT; AGED; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE SUBPOPULATION; MALE; NON SMALL CELL LUNG CANCER; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

EID: 84949554848     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00556     Document Type: Article

References (47)

1. Worldwide Cancer Statistics Cancer Research UK. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/worldwide-cancer#heading-Zero.
2. Mirsadraee S, Oswal D, Alizadeh Y, Caulo A, van Beek EJ. The 7th lung cancer TNM classification and staging system: review of the changes and implications. World J Radiol (2012) 4:128-34. doi: 10.4329/wjr.v4.i4.128.
3. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer J Int Cancer (2001) 94:153-6. doi:10.1002/ijc.1440.
4. Pass HI, Carbone DP, Johnson DH, Minna JD, Scagliotti GV, Turrisi AT. Principles and Practice of Lung Cancer: The Official Reference Text of the International Association for the Study of Lung Cancer (IASLC). Philadelphia: Lippincott Williams & Wilkins (2012).
5. Oberije C, De Ruysscher D, Houben R, van de Heuvel M, Uyterlinde W, Deasy JO, et al. A validated prediction model for overall survival from stage III non-small cell lung cancer: toward survival prediction for individual patients. Int J Radiat Oncol Biol Phys (2015) 92:935-44. doi:10.1016/j.ijrobp.2015.02.048.
6. Breakthrough of the Year 2013 Science/AAAS News. Available from: http://news.sciencemag.org/breakthrough-of-the-year-2013#.Vb38J_nwh_8.
7. Hantschel M, Pfister K, Jordan A, Scholz R, Andreesen R, Schmitz G, et al. Hsp70 plasma membrane expression on primary tumor biopsy material and bone marrow of leukemic patients. Cell Stress Chaperones (2000) 5:438-42. doi:10.1379/1466-1268(2000)005<0438:HPMEOP>2.0.CO;2.
8. Pfister K, Radons J, Busch R, Tidball JG, Pfeifer M, Freitag L, et al. Patient survival by Hsp70 membrane phenotype: association with different routes of metastasis. Cancer (2007) 110:926-35. doi:10.1002/cncr.22864.
9. Lindquist S, Craig EA. The heat-shock proteins. Annu Rev Genet (1988) 22:631-77. doi:10.1146/annurev.ge.22.120188.003215.
10. Hartl FU. Molecular chaperones in cellular protein folding. Nature (1996) 381:571-9. doi:10.1038/381571a0.
11. Gehrmann M, Marienhagen J, Eichholtz-Wirth H, Fritz E, Ellwart J, Jäättelä M, et al. Dual function of membrane-bound heat shock protein 70 (Hsp70), Bag-4, and Hsp40: protection against radiation-induced effects and target structure for natural killer cells. Cell Death Differ (2005) 12:38-51. doi:10.1038/sj.cdd.4401510.
12. Gastpar R, Gehrmann M, Bausero MA, Asea A, Gross C, Schroeder JA, et al. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res (2005) 65:5238-47. doi:10.1158/0008-5472.CAN-04-3804.
13. Breuninger S, Ertl J, Bayer C, Knape C, Gunther S, Regel I, et al. Quantitative analysis of liposomal heat shock protein 70 (Hsp70) in the blood of tumor patients using a novel lipHsp70 ELISA. J Clin Cell Immunol (2015) 5:4-10. doi:10.4172/2155-9899.1000264.
14. MulthoffG, Hightower LE. Distinguishing integral and receptor-bound heat shock protein 70 (Hsp70) on the cell surface by Hsp70-specific antibodies. Cell Stress Chaperones (2011) 16:251-5. doi:10.1007/s12192-010-0247-1.
15. Stangl S, Gehrmann M, Riegger J, Kuhs K, Riederer I, Sievert W, et al. Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody. Proc Natl Acad Sci U S A (2011) 108:733-8. doi:10.1073/pnas.1016065108.
16. Murakami N, Kühnel A, Schmid TE, Ilicic K, Stangl S, Braun IS, et al. Role of membrane Hsp70 in radiation sensitivity of tumor cells. Radiat Oncol (2015) 10:149. doi:10.1186/s13014-015-0461-1.
17. Krause SW, Gastpar R, Andreesen R, Gross C, Ullrich H, Thonigs G, et al. Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase I trial. Clin Cancer Res (2004) 10:3699-707. doi:10.1158/1078-0432.CCR-03-0683.
18. Specht HM, Ahrens N, Blankenstein C, Duell T, Fietkau R, Gaipl US, et al. Heat shock protein 70 (Hsp70) peptide activated natural killer (NK) cells for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCTx)-from preclinical studies to a clinical phase II trial. Front Immunol (2015) 6. doi:10.3389/fimmu.2015.00162.
19. Gastpar R, Gross C, Rossbacher L, Ellwart J, Riegger J, MulthoffG. The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells. J Immunol (2004) 172:972-80.
20. Moser C, Schmidbauer C, Gürtler U, Gross C, Gehrmann M, Thonigs G, et al. Inhibition of tumor growth in mice with severe combined immunodeficiency is mediated by heat shock protein 70 (Hsp70)-peptide-activated, CD94 positive natural killer cells. Cell Stress Chaperones (2002) 7:365-73. doi:10.1379/1466-1268(2002)007<0365:IOTGIM>2.0.CO;2.
21. Gross C, Koelch W, DeMaio A, Arispe N, MulthoffG. Cell surface-bound heat shock protein 70 (Hsp70) mediates perforin-independent apoptosis by specific binding and uptake of granzyme B. J Biol Chem (2003) 278:41173-81. doi:10.1074/jbc. M302644200.
22. Ostheimer C, Bache M, Güttler A, Kotzsch M, Vordermark D. A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor. Strahlenther Onkol Organ Dtsch Röntgenges Al (2014) 190:276-82. doi:10.1007/s00066-013-0484-1.
23. Vega VL, Rodríguez-Silva M, Frey T, Gehrmann M, Diaz JC, Steinem C, et al. Hsp70 translocates into the plasma membrane after stress and is released into the extracellular environment in a membrane-associated form that activates macrophages. J Immunol (2008) 180:4299-307.
24. Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity (2004) 21:137-48. doi:10.1016/j.immuni.2004.07.017.
25. Gehrmann M, Cervello M, Montalto G, Cappello F, Gulino A, Knape C, et al. Heat shock protein 70 serum levels differ significantly in patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Front Immunol (2014) 5:307. doi:10.3389/fimmu.2014.00307.
26. Zimmermann M, Nickl S, Lambers C, Hacker S, Mitterbauer A, Hoetzenecker K, et al. Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: a multi-institutional case-control study. Clin Chim Acta (2012) 413:1115-20. doi:10.1016/j.cca.2012.03.008.
27. Schwarzer J, MulthoffG. Commentary to: "a comparison of two commercially available ELISA methods for the quantification of human plasma heat shock protein 70 during rest and exercise stress" by Lee et al. 2015. Cell Stress Chaperones (2015) 20:865-6. doi:10.1007/s12192-015-0626-8.
28. Bauer K, Nitsche U, Slotta-Huspenina J, Drecoll E, von Weyhern CH, Rosenberg R, et al. High HSP27 and HSP70 expression levels are independent adverse prognostic factors in primary resected colon cancer. Cell Oncol (Dordr) (2012) 35:197-205. doi:10.1007/s13402-012-0079-3.
29. Yuh WTC, Mayr NA, Jarjoura D, Wu D, Grecula JC, Lo SS, et al. Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer. Invest Radiol (2009) 44:343-50. doi:10.1097/RLI.0b013e3181a64ce9.
30. Huang Z, Mayr NA, Yuh WTC, Lo SS, Montebello JF, Grecula JC, et al. Outcome prediction of cervical cancer: kinetic model of tumor regression during radiation therapy. Cancer Res (2010) 70:463. doi:10.1158/0008-5472.CAN-09-2501.
31. Gehrmann M, Specht HM, Bayer C, Brandstetter M, Chizzali B, Duma M, et al. Hsp70-a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck. Radiat Oncol (2014) 9:131. doi:10.1186/1748-717X-9-131.
32. Mambula SS, Calderwood SK. Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes. J Immunol (2006) 177:7849-57. doi:10.4049/jimmunol.177.11.7849.
33. Juhasz K, Lipp A-M, Nimmervoll B, Sonnleitner A, Hesse J, Haselgruebler T, et al. The complex function of hsp70 in metastatic cancer. Cancers (Basel) (2013) 6:42-66. doi:10.3390/cancers6010042.
34. Gehrmann M, Schmetzer H, Eissner G, Haferlach T, Hiddemann W, MulthoffG. Membrane-bound heat shock protein 70 (Hsp70) in acute myeloid leukemia: a tumor specific recognition structure for the cytolytic activity of autologous NK cells. Haematologica (2003) 88:474-6.
35. Botzler C, Li G, Issels RD, MulthoffG. Definition of extracellular localized epitopes of Hsp70 involved in an NK immune response. Cell Stress Chaperones (1998) 3:6-11. doi:10.1379/1466-1268(1998)003<0006:DOELEO>2.3.CO;2.
36. Blankenstein T, Coulie PG, Gilboa E, Jaffee EM. The determinants of tumour immunogenicity. Nat Rev Cancer (2012) 12:307-13. doi:10.1038/nrc3246.
37. Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature (1998) 391:795-9. doi:10.1038/35869.
38. López-Botet M, Pérez-Villar JJ, Carretero M, Rodríguez A, Melero I, Bellón T, et al. Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules. Immunol Rev (1997) 155:165-74. doi:10.1111/j.1600-065X.1997.tb00949.x.
39. Borrego F, Robertson MJ, Ritz J, Pena J, Solana R. CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor. Immunology (1999) 97:159-65. doi:10.1046/j.1365-2567.1999.00738.x.
40. Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M, et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A (2001) 98:13784-9. doi:10.1073/pnas.241500798.
41. Johansson MH, Bieberich C, Jay G, Kärre K, Höglund P. Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene. J Exp Med (1997) 186:353-64. doi:10.1084/jem.186.3.353.
42. MulthoffG, Botzler C, Jennen L, Schmidt J, Ellwart J, Issels R. Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. J Immunol (1997) 158:4341-50.
43. Diefenbach A, Jensen ER, Jamieson AM, Raulet DH. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature (2001) 413:165-71. doi:10.1038/35093109.
44. Kelly JM, Darcy PK, Markby JL, Godfrey DI, Takeda K, Yagita H, et al. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat Immunol (2002) 3:83-90. doi:10.1038/ni746.
45. Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet (2000) 356:1795-9. doi:10.1016/S0140-6736(00)03231-1.
46. Fox J, Ford E, Redmond K, Zhou J, Wong J, Song DY. Quantification of tumor volume changes during radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2009) 74:341-8. doi:10.1016/j.ijrobp.2008.07.063.
47. Wang JZ, Mayr NA, Zhang D, Li K, Grecula JC, Montebello JF, et al. Sequential magnetic resonance imaging of cervical cancer: the predictive value of absolute tumor volume and regression ratio measured before, during, and after radiation therapy. Cancer (2010) 116:5093-101. doi:10.1002/cncr.25260.